BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Napo Pharmaceuticals Endorses Prevention Access Campaign’s U=U Consensus Statement for People Living With HIV/AIDS (PLWHA)

  Napo Pharmaceuticals announced today that it has joined more than 400 organizations from 59 countries in supporting the U=U Consensus Statement.

  October 18, 2017

   · 

  7 min read
• Biotech Bay

  Entatio Announced the Release of Entatio for Pharma, a Media Application Designed to Connect Medical Researchers and Physicians

  Entatio today announced the release of Entatio for Pharma, a cloud application built specifically for pharmaceutical and medical device companies to aid in the delivery of highly regulated medical content to physicians through medical conferences and events.

  October 18, 2017

   · 

  2 min read
• Business

  Pressure BioSciences and Phasex Announce Strategic Collaboration Addressing Broad Markets for Stable, Water-Soluble Nanoemulsions

  Pressure BioSciences announced a collaboration with Phasex Corporation, one the world’s most experienced supercritical fluid (“SCF”)-based toll processors.

  October 18, 2017

   · 

  7 min read
• Drug Development

  Spyryx Biosciences Announces First Patient Enrolled in Phase II Clinical Trial of SPX-101 for the Treatment of Cystic Fibrosis

  Spyryx Biosciences today announced the first patient was dosed in the HOPE-1 study, a multinational Phase 2 clinical trial for its lead compound, SPX-101 in cystic fibrosis.

  October 18, 2017

   · 

  5 min read
• Deals

  BD Statement On European Commission Conditional Clearance Of Bard Acquisition

  BD issued the following statement regarding today’s clearance by the European Commission for BD to acquire C.R. Bard contingent on BD divesting its soft tissue core needle biopsy product line.

  October 18, 2017

   · 

  2 min read
• Pharm Country

  Adobe Sign Certified Compliant with SAFE-BioPharma Standard

  Adobe Sign, the leading e-signature solution that allows anyone to sign and send documents, is now certified compliant with the global SAFE-BioPharma digital signature standard.

  October 18, 2017

   · 

  2 min read
• Business

  Dune Medical Strengthens Leadership Team, Names Skip Ashmore as CCO

  Ashmore joins Dune with 25 years of experience in the medical device industry including engagements with Covidien, CryoLife, Baxter and Motus GI.

  October 18, 2017

   · 

  2 min read
• 

  Biotech Beach

  TearLab Tweaks Regulatory Strategy for Next-Generation In-Vitro Diagnostics Testing Platform

  Company Remains on-track to submit 510(k) application in 2017.

  October 18, 2017

   · 

  3 min read
• BioMidwest

  Life Spine Announces Alpha Release Of The SENTRY ALIF Plating System

  Life Spine, a medical device company that designs, develops, manufactures, and markets products for the surgical treatment of spinal disorders today announced the Alpha launch of the SENTRY ALIF Plating System.

  October 18, 2017

   · 

  1 min read
• Drug Development

  New Study Comparing Effectiveness of Alkermes’ Extended-Release Naltrexone to Buprenorphine-Naloxone for Opioid Dependence Published in JAMA Psychiatry

  Results were published this week in the Journal of the American Medical Association Psychiatry.

  October 18, 2017

   · 

  15 min read